Cargando…

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR

BACKGROUND: Myocardial extracellular volume (ECV) is elevated in fibrosis or infiltration and can be quantified by measuring the haematocrit with pre and post contrast T1 at sufficient contrast equilibrium. Equilibrium CMR (EQ-CMR), using a bolus-infusion protocol, has been shown to provide robust m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontana, Marianna, White, Steve K, Banypersad, Sanjay M, Sado, Daniel M, Maestrini, Viviana, Flett, Andrew S, Piechnik, Stefan K, Neubauer, Stefan, Roberts, Neil, Moon, James C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552758/ https://www.ncbi.nlm.nih.gov/pubmed/23272651 http://dx.doi.org/10.1186/1532-429X-14-88

Ejemplares similares

Histological validation of ShMOLLI equilibrium contrast CMR for the measurement of diffuse myocardial fibrosis
por: White, Steven K, et al.
Publicado: (2012)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

T1- and ECV-mapping in clinical routine at 3 T: differences between MOLLI, ShMOLLI and SASHA
por: Heidenreich, Julius F., et al.
Publicado: (2019)

Single breath-hold Vd(m) calculation as good as multi breath-hold technique in Equilibrium Contrast CMR
por: Sado, Daniel, et al.
Publicado: (2012)

Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI
por: Piechnik, Stefan K, et al.
Publicado: (2013)

Age and gender dependence of pre-contrast T1-relaxation times in normal human myocardium at 1.5T using ShMOLLI
por: Piechnik, Stefan K, et al.
Publicado: (2012)

Systolic ShMOLLI T1-mapping is feasible in tachyarrhythmia, with improved image quality compared to diastolic readout
por: Wijesurendra, Rohan S, et al.
Publicado: (2015)

Comparison of MOLLI and ShMOLLI in Terms of T1 Reactivity and the Relationship between T1 Reactivity and Conventional Signs of Response during Adenosine Stress Perfusion CMR
por: Gezmiş, Esin, et al.
Publicado: (2020)

Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias
por: Ferreira, Vanessa M., et al.
Publicado: (2015)

ShMOLLI and 5(4R) 3 MOLLI T1 mapping in HCM detect similar ECV despite a difference in absolute T1 measurements
por: Gonzalez, Jorge A, et al.
Publicado: (2015)

Quantification of acute myocardial injury by ShMOLLI T1-Mapping, T2-weighted and late gadolinium imaging in patients presenting with chest pain, positive troponins and non-obstructive coronary arteries
por: Ferreira, Vanessa M, et al.
Publicado: (2011)

Continuous quantitative mapping of multi-organ T1 relaxation times with ShMOLLI to assess dose response in respiratory challenges at 3T
por: Piechnik, SK, et al.
Publicado: (2013)

Assessment of the interstitial volume in healthy volunteers. An equilibrium contrast CMR study
por: Sado, Daniel, et al.
Publicado: (2012)

Reproducibility of native T1 mapping using ShMOLLI and MOLLI - implications for sample size calculation
por: Bhuva, Anish N, et al.
Publicado: (2016)

Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold
por: Piechnik, Stefan K, et al.
Publicado: (2010)

Age-gender reference values of native myocardial T1 at 1.5T and 3T: comparison of MOLLI and shMOLLI
por: Dabir, Darius, et al.
Publicado: (2013)

Interstitial expansion in health and disease - an equilibrium contrast CMR study
por: Sado, Daniel, et al.
Publicado: (2012)

Are T1 values to characterize myocardial tissue equivalent between various sequences: comparison of MOLLI, shMOLLI, 3'5-MOLLI and SASHA
por: Puntmann, Valentina O, et al.
Publicado: (2013)

Accuracy and precision of myocardial T(1)mapping with MOLLI and ShMOLLI at 1.5T and 3.0T: a phantom study
por: Falque, Claire, et al.
Publicado: (2014)

Accuracy and reproducibility of four T(1 )mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE
por: Roujol, Sébastien, et al.
Publicado: (2014)

Comparison of MOLLI and ShMOLLI at 1.5 and 3 Tesla for detection of early cardiac iron deposition in patients with transfusional siderosis
por: Cheng, Andrew L, et al.
Publicado: (2016)

Standardization of myocardial T1 time measurements in clinical setting using MOLLI, shMOLLI and LL at 1.5T and 3T - the CONSEPT study
por: Rogers, Toby, et al.
Publicado: (2013)

The quantification and role of diffuse myocardial fibrosis in familial dilated cardiomyopathy - an equilibrium contrast cmr study
por: Sado, Daniel M, et al.
Publicado: (2011)

T1 values in discrimination between health and disease using different T1 sequences: comparison between 3'3'5-MOLLI, 3'5-MOLLI, shMOLLI and SASHA
por: Mahmoud, Islam Z, et al.
Publicado: (2014)

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
por: Banypersad, Sanjay M, et al.
Publicado: (2013)

An instantaneous ECV with no blood sampling: using native blood T1 for hematocrit is as good as standard ECV
por: Treibel, Thomas A, et al.
Publicado: (2015)

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
por: Fontana , Marianna, et al.
Publicado: (2014)

Reproducibility of multiple T1 Mapping techniques and to ECV quantification
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Beyond late gadolinium enhancement: the key role of diffuse myocardial fibrosis in severe aortic stenosis - an Equilibrium Contrast CMR study
por: Flett, Andrew S, et al.
Publicado: (2011)

The effect of gender, piloting and segmental analysis on T1 quantification in normal individuals using MOLLI
por: Abbas, Ausami, et al.
Publicado: (2014)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

Value of ECV quantification in PAH: correlation with echocardiographic, MRI and serum biomarkers
por: Hubert, Sandrine, et al.
Publicado: (2015)

Performance of automated ECV maps versus conventionally calculated ECV
por: Rosmini, Stefania, et al.
Publicado: (2015)

Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
por: Scully, Paul R., et al.
Publicado: (2020)

A T1 and ECV phantom for global T1 mapping quality assurance: The T(1) mapping and ECV standardisation in CMR (T1MES) program
por: Captur, Gaby, et al.
Publicado: (2016)

CMR-derived ECVs vary with myocardial region and associate with the regional wall thickness
por: Su, Mao-Yuan, et al.
Publicado: (2020)

Myocardial strain in a health and disease: CMR feature tracking analysis in cardiac hypertrophy
por: Barison, Andrea, et al.
Publicado: (2013)

Extracellular volume quantification in isolated hypertension - changes at the detectable limits?
por: Treibel, Thomas A., et al.
Publicado: (2015)

Accelerated cloud and GPU-based simulations for quantification of relaxation times: an example with MOLLI
por: Kantasis, Georgios, et al.
Publicado: (2016)

Myocardial iron quantification using T2* and native T1mapping - a 250 patient study
por: Abdel-Gadir, Amna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h1thct41uq2pghdnejo15j95eh